SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001396814-19-000008
Filing Date
2019-02-28
Accepted
2019-02-28 17:06:03
Documents
93
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K - PCRX - 12.31.2018 pcrx-12312018x10k.htm 10-K 2211307
2 EXHIBIT 10.41 pcrx-12312018xex1041.htm EX-10.41 15321
3 EXHIBIT 21.1 pcrx-12312018xex211.htm EX-21.1 2630
4 EXHIBIT 23.1 pcrx-12312018xex231.htm EX-23.1 4359
5 EXHIBIT 31.1 pcrx-12312018xex311.htm EX-31.1 10689
6 EXHIBIT 31.2 pcrx-12312018xex312.htm EX-31.2 10984
7 EXHIBIT 32.1 pcrx-12312018xex321.htm EX-32.1 4310
8 EXHIBIT 32.2 pcrx-12312018xex322.htm EX-32.2 4202
15 item5colorcharta04.jpg GRAPHIC 69794
16 paciralogoa10.jpg GRAPHIC 63011
  Complete submission text file 0001396814-19-000008.txt   10452110

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT pcrx-20181231.xml EX-101.INS 2189599
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20181231.xsd EX-101.SCH 69196
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20181231_cal.xml EX-101.CAL 100437
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20181231_def.xml EX-101.DEF 368850
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20181231_lab.xml EX-101.LAB 985484
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20181231_pre.xml EX-101.PRE 546246
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35060 | Film No.: 19644633
SIC: 2834 Pharmaceutical Preparations